AMİRFALLAH, A. Et Al. 2012. 5 Fluorouracil methabolic pathway genetic polymorphisms were associated with treatment related toxicity Pharmacogenomic analysis. ISC Conference on Innovative Therapies , (İstanbul, Turkey), 6.

AMİRFALLAH, A., ÇALIBAŞI, G., ÜNAL, O. Ü., BASKIN, Y., ÖZTOP, İ., ELLİDOKUZ, H., ... YILMAZ, A. U.(2012). 5 Fluorouracil methabolic pathway genetic polymorphisms were associated with treatment related toxicity Pharmacogenomic analysis . ISC Conference on Innovative Therapies (pp.6). İstanbul, Turkey

AMİRFALLAH, ARSALAN Et Al. "5 Fluorouracil methabolic pathway genetic polymorphisms were associated with treatment related toxicity Pharmacogenomic analysis," ISC Conference on Innovative Therapies, İstanbul, Turkey, 2012

AMİRFALLAH, ARSALAN Et Al. "5 Fluorouracil methabolic pathway genetic polymorphisms were associated with treatment related toxicity Pharmacogenomic analysis." ISC Conference on Innovative Therapies , İstanbul, Turkey, pp.6, 2012

AMİRFALLAH, A. Et Al. (2012) . "5 Fluorouracil methabolic pathway genetic polymorphisms were associated with treatment related toxicity Pharmacogenomic analysis." ISC Conference on Innovative Therapies , İstanbul, Turkey, p.6.

@conferencepaper{conferencepaper, author={ARSALAN AMİRFALLAH Et Al. }, title={5 Fluorouracil methabolic pathway genetic polymorphisms were associated with treatment related toxicity Pharmacogenomic analysis}, congress name={ISC Conference on Innovative Therapies}, city={İstanbul}, country={Turkey}, year={2012}, pages={6} }